Skip to main content

Table 6 Estimated maternal and child health benefits of a 1-year inhaled oxytocin introduction program over a lifetime horizon with a 3% discount rate

From: Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings

 

Bangladesh

Ethiopia

Status quo

Intervention

Averted

Status quo

Intervention

Averted

PPH cases, non-severe

291,978

278,813

13,165

297,868

295,672

2197

PPH cases, severe

150,947

145,467

5479

155,178

154,264

914

Maternal deaths

1806

1730

76

4418

4388

30

Maternal life years lost

46,429

44,475

1954

111,767

111,000

767

Child deaths

1135

1088

48

3394

3371

23

Child life years lost

33,480

32,071

1409

97,284

96,616

668

  1. PPH postpartum haemorrhage